Allen Krantz, 1940 - 2018
Dr. Krantz served on Chemistry faculty from 1968 to 1980. His research included using
photochemical reactions in inert low-temperature matrices to make highly reactive
species such as cyclobutadiene. After he left Stony Brook, Dr. Krantz held several
high-level positions in the pharmaceutical industry, and founded Advanced Proteome
Therapeutics, where he served as Chief Scientific Officer and COO.